
Discover if this is a suitable investor for your startup. If they are we'll make a warm introduction for free. Otherwise, we'll connect you with matching investors.
Cycad Group is a venture capital firm based in Santa Barbara, California, founded by Charles “Pete” Conrad, Jr. The firm focuses on investing in technology companies that address unmet clinical needs and other innovative sectors. Since its inception, Cycad Group has built a portfolio of 12 companies, demonstrating its commitment to supporting advancements in healthcare and technology.
The firm operates from its office located at 1270 Coast Village Circle, Suite 100, Santa Barbara, CA 93108. Cycad Group has established itself as a key player in the venture capital space, particularly in sectors that require innovative solutions to pressing medical and technological challenges. The firm’s assets under management (AUM) and specific fund sizes are not publicly disclosed, but its investment strategy reflects a strong focus on impactful sectors.
Cycad Group's investment strategy encompasses a diverse range of sectors, with a primary emphasis on technology and healthcare. The firm invests across various stages of development, including pre-seed, seed, seed-plus, Series A, Series B, and Series C. This broad stage range allows Cycad Group to support companies at different points in their growth trajectory.
Particularly, Cycad Group seeks out companies that provide innovative solutions to significant medical and technological challenges. Their focus on addressing unmet clinical needs positions them as a valuable partner for startups in the healthcare and biotech sectors. The firm’s investment criteria include a strong emphasis on the potential for transformative impact in the healthcare landscape and technological advancements.
Cycad Group's portfolio includes a diverse array of companies that are making strides in healthcare, technology, and energy. Notable portfolio companies include:
Charles “Pete” Conrad, Jr. - Founder. Charles has a background in venture capital and has led numerous investments in technology and healthcare sectors. His expertise lies in identifying innovative solutions that address critical challenges in these fields.
Submit your pitch through their website's contact form for consideration.
What are Cycad Group's investment criteria?
Cycad Group focuses on technology and healthcare sectors, investing in companies that address unmet clinical needs and provide innovative solutions. They consider companies at various stages, from pre-seed to Series C.
How can I apply or pitch to Cycad Group?
Founders can reach out through the contact information provided on their website. A well-prepared pitch deck that outlines the business model, market opportunity, and team background is essential.
What makes Cycad Group different from other venture capital firms?
Cycad Group's distinct focus on technology and healthcare, particularly in addressing significant medical challenges, sets it apart. Their commitment to supporting innovations that can have a transformative impact is a key differentiator.
What is Cycad Group's geographic scope?
The firm primarily invests in North America, specifically within the United States, allowing them to closely monitor and support their portfolio companies.
What is Cycad Group's post-investment involvement like?
Cycad Group actively engages with its portfolio companies, providing mentorship and resources to help them navigate challenges and scale effectively. They often take board seats to ensure alignment and support.
What is the typical check size for investments?
While specific check sizes are not disclosed, Cycad Group invests across a range of stages, indicating flexibility in their investment amounts based on the needs of the company.
All trademarks, logos and brand names are the property of their respective owners. All company, product and service names used in this website are for identification purposes only. Use of these names, trademarks, and brands does not imply endorsement.